Medications

Researchers to test blood cancer drug in COVID-19 patients

Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus. The test follows several case reports in which the drug, ibrutinib, appeared to ...

Diseases, Conditions, Syndromes

Physiotherapeutic support in COVID-19 recovery

New physiotherapy guidelines are targeting COVID-19 patient recovery for respiratory management, exercise and mobilization in acute hospital wards and Intensive Care Units.

Diseases, Conditions, Syndromes

Hypertension, obesity, diabetes common in U.S. COVID-19 patients

(HealthDay)—The most common comorbidities among patients hospitalized with COVID-19 in the New York City area are hypertension, obesity, and diabetes, according to a study published online April 22 in the Journal of the ...

Medications

Hydroxychloroquine seems not to cut ventilator use in COVID-19

There is no evidence that use of hydroxychloroquine alone (HC) or with azithromycin (HC+AZ) reduces the risks for mechanical ventilation or death from any cause in patients hospitalized with COVID-19, according to a study ...

page 8 from 14